Allarity Therapeutics Inc.

Allarity Therapeutics - Allarity Therapeutics

Allarity Therapeutics is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for ...

Allarity Therapeutics, Inc. (ALLR) - Yahoo Finance

Allarity Therapeutics, Inc. (ALLR) · -2.22% · -7.69% · -94.42% · -99.60% · -99.54% · -100.00% · -100.00%.

Allarity Therapeutics Outlines Company's 2024 Progress ... - BioSpace

Allarity Therapeutics, Inc. (NASDAQ: ALLR) is a clinical-stage biopharmaceutical company dedicated to developing personalized cancer treatments.

Allarity Therapeutics Outlines Company's 2024 Progress and ...

Boston (July 22, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

Allarity Therapeutics (@AllarityTx) / X

Allarity Therapeutics, Inc. is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients.

Allarity Therapeutics Inc (ALLR) Stock Price & News - Google Finance

Get the latest Allarity Therapeutics Inc (ALLR) real-time quote, historical performance, charts, and other financial information to help you make more ...

Allarity Therapeutics Takes Decisive Step Toward Regaining

Boston (September 11, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical ...

Allarity Therapeutics, Inc. - AnnualReports.com

Allarity Therapeutics, Inc. ... Allarity Therapeutics, Inc. (Nasdaq: ALLR) develops drugs for personalized treatment of cancer guided by its proprietary and ...

Allarity Therapeutics Inc. Stock Quote (U.S. - ALLR - MarketWatch

ALLR | Complete Allarity Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Allarity Therapeutics Inc - Reuters

Get Allarity Therapeutics Inc (ALLR.OQ) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.

Allarity Therapeutics Announces Reverse Stock Split of - SEC.gov

Allarity Therapeutics, Inc. (Nasdaq: ALLR) develops drugs for personalized treatment of cancer guided by its proprietary and highly validated companion ...

Allarity Therapeutics, Inc. Class Action - Robbins LLP

Robbins LLP is investigating allegations that Allarity Therapeutics, Inc. (ALLR) misled investors regarding Dovitinib NDA's regulatory prospects.

Allarity Therapeutics, Inc. Common Stock (ALLR) - Nasdaq

Discover real-time Allarity Therapeutics, Inc. Common Stock (ALLR) stock prices, quotes, historical data, news, and Insights for informed trading and ...

ALLR - Allarity Therapeutics, Inc. Latest Stock News & Market Updates

Allarity Therapeutics Announces Appointment of New Auditor ... Allarity Therapeutics, Inc. (Nasdaq: ALLR) announced the appointment of Wolf & Company as its ...

Allarity Therapeutics, Inc. Contracts & Agreements | Justia

Search Allarity Therapeutics, Inc. business contracts filed with the Securities and Exchange Commission.

Allarity Therapeutics, Inc. - Glancy Prongay & Murray LLP

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as ...

ALLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC ...

A class action lawsuit has been filed against Allarity Therapeutics, Inc. (Allarity or the Company) (NASDAQ: ALLR) and certain of its officers.

Allarity Therapeutics, Inc. - Edelson Lechtzin LLP

Allarity Therapeutics, based in Boston, Massachusetts, is a biopharmaceutical company focused on oncology therapeutics. Its drug candidates include Dovitinib, a ...

ALLR | Allarity Therapeutics Inc. Stock Overview (U.S.: Nasdaq)

Complete Allarity Therapeutics Inc. stock information by Barron's. View real-time ALLR stock price and news, along with industry-best analysis.

Allarity Therapeutics Inc - Company Profile and News

Company profile page for Allarity Therapeutics Inc including stock price, company news, executives, board members, and contact information.